Keywords
How to Cite
Abstract
The conceptualization of the tumor microenvironment (TME) has evolved from that of a passive structural scaffold to a dynamic, co-evolutionary ecosystem that actively dictates cancer progression, immune evasion, and therapeutic resistance. Far from a monolithic entity, the TME comprises a heterogeneous assembly of stromal fibroblasts, infiltrating immune cells, aberrant vasculature, and a chemically and physically modified extracellular matrix (ECM). These components engage in intricate, bi-directional molecular dialogues with neoplastic cells through soluble cytokines, metabolic competition, extracellular vesicles, and mechanotransduction pathways. This comprehensive review provides an exhaustive analysis of the molecular interactions within the TME, dissecting the functional plasticity of cancer-associated fibroblasts (CAFs)—including the myofibroblastic (myCAF), inflammatory (iCAF), and antigen-presenting (apCAF) subtypes—and the metabolic crosstalk driving T-cell exhaustion and macrophage polarization. Furthermore, we explore the profound impact of the intratumoral microbiome on therapeutic outcomes and the application of spatial transcriptomics to map cellular neighborhoods. Finally, we critically evaluate next-generation therapeutic strategies, such as stromal normalization, metabolic checkpoint inhibition, and STING pathway activation, designed to reengineer the TME from a pro-tumorigenic sanctuary into a hostile niche for malignancy